Table 1 Demographic and clinical characteristics of patients in Cohort #1, Cohort #2 and Cohort #3.
Training cohort (Cohort #1, N = 70) | Validation cohort (Cohort #2, N = 119) | Validation cohort (Cohort #3, N = 116) | |
|---|---|---|---|
Median age | 62.4 | 65.4 | 66.8 |
Gender | |||
Male (%) | 84.3 | 47.9 | 55.2 |
Female (%) | 15.7 | 52.1 | 44.8 |
Stage | |||
I (%) | 64.3 | 81.1 | 66.4 |
II (%) | 35.7 | 18.9 | 33.6 |
T-Stage | |||
T1 (%) | 19.1 | 51.3 | 51.7 |
T2 (%) | 80.9 | 48.7 | 48.3 |
N-Stage | |||
N0 (%) | 74.3 | 53.8 | 79.3 |
N1 (%) | 25.7 | 46.2 | 20.7 |
Non-recurrence (%) | 51.4 | 54.6 | 67.2 |
Recurrence (%) | 48.6 | 45.4 | 32.8 |